Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting

  • Hussien Ahmed, Ali Mohamed Hammad, Abdelrahman Ibrahim Abushouk, Mohamed Zidan, Mohamed Salem, Ahmed Negida, Mohamed M. Abdel-Daim
  • Current Problems in Cancer, December 2017, Elsevier
  • DOI: 10.1016/j.currproblcancer.2017.11.003

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.currproblcancer.2017.11.003

The following have contributed to this page: Dr Mohamed M Abdel-Daim